Clinical trials recruiting for End-stage renal disease

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)
  NCT07348237 · Phase: Phase 1 · Ages: 24 Years to 85 Years · Sex: All (male and female) · 3 locations
• AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
  NCT04392206 · Phase: Phase 1 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Acoustic Analysis of VA Sounds
  NCT05612022 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL
  NCT06032208 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Blood Flow Conditions and Sounds in AVFs
  NCT06411353 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
  NCT04163614 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• CAPABLE Transplant
  NCT06326905 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 99 Years · Sex: All (male and female) · 2 locations
• CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
  NCT05726526 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
  NCT07053462 · Phase: Phase 1, Phase 2 · Ages: 16 Years to 85 Years · Sex: All (male and female) · 1 location
• CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
  NCT05931276 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Cardio-Renal Registry
  NCT06521801 · Phase: Not specified · Ages: 16 Years and older · Sex: All (male and female) · 1 location
• CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease
  NCT05422534 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Comparative Study of Prognosis and QOL Between APD-RPM and CAPD
  NCT05738525 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis
  NCT06341452 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry
  NCT05880537 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors
  NCT03803423 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Drug Interaction Potential of Pro-Inflammatory Conditions
  NCT07360938 · Phase: Not specified · Ages: 12 Years to 99 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
  NCT03994471 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 41 locations
• Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates
  NCT05917795 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• French Renal Epidemiology and Information Network (REIN) Registry
  NCT03967808 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Heparin-Free Chronic HemoDialysis Assessment
  NCT06224140 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
  NCT03321656 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Impact on Quality of Life of Symptoms Routine E-monitoring Among Dialysis Patients.
  NCT06257134 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis
  NCT04399941 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
  NCT06190717 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 84 Years · Sex: All (male and female) · 21 locations
• Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis
  NCT05705414 · Phase: Early Phase 1 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 1 location
• PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
  NCT06422871 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Partners Calciphylaxis Biobank
  NCT03032835 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
  NCT06516653 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 9 locations
• Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
  NCT04634916 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 17 locations
• Preference of Life-Sustaining Treatment Among Patients With End Stage Renal Disease
  NCT05878171 · Phase: Not specified · Ages: 20 Years and older · Sex: All (male and female) · 2 locations
• Pumpkin Seed Oil as a Nutraceutical for Hemodialysis Patients
  NCT07710183 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter & Genius 90 Concentrates in Haemodialysis Patients
  NCT05282732 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Rheopheresis as Adjuvant Treatment of Calciphylaxis
  NCT04654000 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 29 locations
• SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
  NCT06001827 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 28 locations
• Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
  NCT04580420 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · 18 locations
• Safety and Efficacy of Empagliflozin in Hemodialysis
  NCT05786443 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Solv Multi-Pass Hemodialysis System In-Center Clinical Study
  NCT07216885 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of the Quality of Life in School Aged-children With Posterior Urethral Valves
  NCT06439862 · Phase: Not specified · Ages: 6 Years to 17 Years · Sex: Male · 1 location
• The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
  NCT03862859 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 13 locations
• The Effect of Intradialytic Exercise on Postural Abnormalities
  NCT07720401 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• The Effect of Intradialytic Eye Exercise in Hemodialysis Patients
  NCT07591714 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients With ESRD
  NCT06982573 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• The Effect of a Prehabilitation Exercise Program on Physical Functioning for Patients Undergoing Kidney Transplantation
  NCT04044963 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• The Microcirculation, Dialysis Modality and Sequestered Salt
  NCT06327750 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• The Role of Toll-like Receptor-4 in Periodontitis Patients With End-stage Renal Disease in a Sample of Egyptian Population
  NCT06755372 · Phase: Not specified · Ages: 30 Years to 60 Years · Sex: All (male and female) · 1 location
• Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors
  NCT05159466 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Ventilatory Functions and Physical Intolerance in ESRD Adolescents: Response to Program of Walking With Dogs
  NCT06861816 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years to 17 Years · Sex: All (male and female) · 1 location
• Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study
  NCT06329310 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Related conditions

Trials recruiting for End-stage renal disease often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for End-stage renal disease trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.